RhumbLine Advisers’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-65,539	Closed	-$17K	–	4420
2023 Q1	$17K	Buy	65,539 +548	+0.8%	+$142	﹤0.01%	2939
2022 Q4	$77K	Buy	64,991 +11,383	+21%	+$13.5K	﹤0.01%	2921
2022 Q3	$109K	Buy	+53,608	New	+$109K	﹤0.01%	2993